-
06-06-2018, 01:36 PM
#16381
Member
Originally Posted by Balance
PEB has done a huge dis-favour to the whole biomed and biotech industry in NZ.
Companies complain often bitterly of lack of access to capital in NZ to develop and commercialize products which is true.
PEB has had access to plenty but instead of being a poster boy of what can be achieved (eg. CSL & Cohlear on ASX), PEB has showed itself to be an unreliable and untrustworthy company to invest in.
Real shame for NZ.
Shame on PEB and the directors and DD.
I wish it wasnt the case... I've heard PEB refered to as 'NZs most successful university startup...."
-
06-06-2018, 02:10 PM
#16382
On my rounds and just a little behind..
Originally Posted by kiwidollabill
I wish it wasnt the case... I've heard PEB refered to as 'NZs most successful university startup...."
Which would be wrong. That accolade in modern times belongs probably to AD Instruments, which wasn't held by the Uni for long.
https://en.wikipedia.org/wiki/ADInstruments
NZs best medical research company is/was Glaxo, which started in Bunnythorpe, Wgtn, later to become part of GSK.
History lesson over.
-
06-06-2018, 03:28 PM
#16383
Originally Posted by drcjp
Which would be wrong. That accolade in modern times belongs probably to AD Instruments, which wasn't held by the Uni for long.
https://en.wikipedia.org/wiki/ADInstruments
NZs best medical research company is/was Glaxo, which started in Bunnythorpe, Wgtn, later to become part of GSK.
History lesson over.
also MOLTENO OPHTHALMIC, started in Dunedin by Professor Tony Moltemo in 1985, exports specialist ophthalmic surgical implants/ equipment all over the world. Outstandingly successful private company, which most people have never of
-
06-06-2018, 03:49 PM
#16384
Originally Posted by Sgt Pepper
also MOLTENO OPHTHALMIC, started in Dunedin by Professor Tony Moltemo in 1985, exports specialist ophthalmic surgical implants/ equipment all over the world. Outstandingly successful private company, which most people have never of
Nice to know.
Bravo!
-
06-06-2018, 08:19 PM
#16385
Member
Originally Posted by drcjp
Which would be wrong. That accolade in modern times belongs probably to AD Instruments, which wasn't held by the Uni for long.
https://en.wikipedia.org/wiki/ADInstruments
NZs best medical research company is/was Glaxo, which started in Bunnythorpe, Wgtn, later to become part of GSK.
History lesson over.
Agree, ADI is a good one. Chatted to Michael McKnight a few times, lives not far from me, by his own account is was many years of hard graft to get where they are.
Molteno is a good one.
I 'thought' Stretchsense were going to be a good modern day example untill they screwed up the deal with their main customer and had to lay off most of the workforce...
-
07-06-2018, 09:27 AM
#16386
https://www.odt.co.nz/business/pacif...ic-new-markets
"Cxbladder to completely replace cytology and be used to complement cystoscopy in the clinical care path for patients presenting to clinicians with haematuria (blood in the urine)," Mr Darling said.
How can you not get excited about the bullishness?
Only problem - it's a blast from the past 7 years ago!
-
07-06-2018, 09:42 AM
#16387
https://www.odt.co.nz/business/pacif...rds-loss-again
For those still looking for inspiration (after being fed a diet of dead rats disguised as 'good' news like great sales growth), there may be hope as '''Canterbury tests are really rocketing,''!!!!!!!!!!
-
07-06-2018, 09:46 AM
#16388
Member
I asked a DHB boss about this statement about 5-6years ago - his response was that it didn't negate the requirement for cystoscopy (as there are other cause of haematuria this would diagnose and treat) and just added test cost to the work up bottom line. Granted it may be useful to "detect" return of bladder ca but it was unclear with this would remove surveillance cystoscopy.
discl - not holding. But held some years ago from 28c to .$1something before I became sadly unconvinced
-
07-06-2018, 09:24 PM
#16389
Originally Posted by Balance
I approached CDHB, I hold NZ media accreditation, seeking comment on PEB / DD's statement. They have declined to comment at this time. Much like Kaiser, another of PEB's 'partners' don't want to talk about their partnership, full stop. You can read into that what you will...
-
08-06-2018, 07:58 AM
#16390
Originally Posted by Hectorplains
I approached CDHB, I hold NZ media accreditation, seeking comment on PEB / DD's statement. They have declined to comment at this time. Much like Kaiser, another of PEB's 'partners' don't want to talk about their partnership, full stop. You can read into that what you will...
With PEB, there is only ever one way to read the wildly positive and exuberant pronouncements of this company and its management - their track record and history tell us that.
It's all PR with very little substance.
DD thinks he is a salesman peddling a miracle cure with such a statement - 'Canterbury tests are really rocketing'.
From 50 tests to 200 tests is certainly 'rocketing' but in the overall scheme of things, is like the proverbial pissing against the wind.
Last edited by Balance; 08-06-2018 at 08:06 AM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks